Skip to main content
. 2022 Oct 19;13:1017391. doi: 10.3389/fphar.2022.1017391

FIGURE 4.

FIGURE 4

ROR for ONJ of denosumab and zoledronic acid with different doses and frequency for different indications. Note: Q4W, every 4 weeks; Q6M, every 6 months, QY, every 1 year.